Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-16 Purchase | 2023-08-16 8:53 pm | Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director | 777,778 | $0.9 | $700,000 | 1,933,671 (Indirect Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 4:11 pm | Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director | 238,095 | $2.1 | $500,000 | 700,205 (Direct) | View |
| 2021-07-06 Purchase | 2021-07-08 6:17 pm | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 35,000 | $16 | $560,000 | 303,919 (Indirect Direct) | View |
| 2020-08-13 Purchase | 2020-08-17 4:39 pm | Verrica Pharmaceuticals Inc. | VRCA | Stalfort Sean Director | 31,250 | $6.4148 | $200,464 | 462,110 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-16 Gift | 2023-08-16 8:53 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director | 50,000 | $0 | 1,933,671 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:48 pm | N/A 2033-06-22 | Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director | 43,800 | $0 | 43,800 (Direct) | View |
Ownership | 2023-06-26 4:46 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director | 0 | $0 | 1,105,893 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:45 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:24 pm | N/A 2032-06-14 | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-07-06 Conversion | 2021-07-08 6:17 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 261,775 | $0 | 303,919 (Direct) | View |
Ownership(A) | 2021-07-08 5:59 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 0 | $0 | 131,595 (Indirect) | View |
| 2021-06-30 Option Award | 2021-07-02 4:20 pm | N/A 2031-06-30 | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 34,000 | $0 | 34,000 (Direct) | View |
Ownership | 2021-06-30 6:59 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director | 0 | $0 | 137,324 (Direct) | View |
| 2019-11-12 Equity Swap | 2019-11-12 4:40 pm | N/A N/A | Dova Pharmaceuticals Inc. | DOVA | Stalfort Sean Director | 635,665 | $27.5 | 0 (Direct) | View |